Skip to main content

Table 1 Characteristic of the study subjects

From: First-degree family history of diabetes and its relationship with serum osteocalcin levels independent of liver fat content in a non-diabetic Chinese cohort

VariablesTotal (n = 1206)Non-FDR (n = 957)FDR (n = 249)
Age (years)59.7 (54.8–64.3)59.9 (54.8–64.4)59.0 (54.0–63.2)
Men, n (%)413 (34.2)337 (35.2)76 (30.5)
BMI (kg/m2)24.0 ± 3.224.0 ± 3.224.2 ± 3.3
W (cm)82.0 (77.0–89.0)82.0 (77.0–88.0)83.0 (77.0–89.8)
SBP (mmHg)129.0 (118.0–141.0)130.0 (119.0–142.0)124.0 (114.0–137.0) **
DBP (mmHg)77.0 (70.0–84.0)77.0 (71.0–85.0)75.0 (68.0–82.0) **
FPG (mmol/L)5.7 ± 0.55.7 ± 0.55.7 ± 0.5
2hPG (mmol/L)7.0 ± 1.87.0 ± 1.77.2 ± 1.8*
HbA1c (%)5.6 (5.4–5.9)5.6 (5.4–5.8)5.7 (5.5–5.9) **
HOMA-IR2.2 (1.5–3.2)2.2 (1.5–3.1)2.2 (1.5–3.3)
TC (mmol/L)5.4 (4.8–6.0)5.4 (4.8–6.0)5.3 (4.8–6.1)
TG (mmol/L)1.4 (1.0–1.9)1.4 (1.0–1.9)1.4 (1.1–2.0)
HDL-C (mmol/L)1.4 (1.2–1.7)1.4 (1.2–1.7)1.4 (1.2–1.7)
LDL-C (mmol/L)3.3 (2.8–3.8)3.3 (2.8–3.8)3.3 (2.8–3.9)
CRP (mg/L)0.9 (0.4–1.6)0.9 (0.4–1.6)0.9 (0.5–1.7)
ALT (U/L)18.0 (14.0–24.0)18.0 (14.0–24.0)18.0 (14.0–24.0)
AST (U/L)20.0 (18.0–24.0)20.0 (18.0–24.0)20.0 (17.5–24.0)
GGT (U/L)22.0 (17.0–31.0)22.0 (17.0–32.0)22.0 (16.0–30.0)
LFC (%)8.2 (6.6–22.2)8.2 (6.6–22.6)8.4 (6.6–16.2)
NAFLD, n (%)479 (39.7)379 (39.6)100 (40.2)
Impaired glucose regulation, n (%)513 (42.5)392 (41.0)121 (48.6) *
  1. Continuous variables are expressed as means ± standard deviation or medians with interquartile range. Categorical variables are expressed as numbers with percentages
  2. FDR versus non-FDR, *P < 0.05, **P < 0.01
  3. FDR first degree relatives of patients with diabetes, BMI body mass index, W waist circumference, SBP systolic blood pressure, DBP diastolic blood pressure, FPG fasting plasma glucose, 2hPG 2-h plasma glucose, HbA1c glycated hemoglobin A1c, HOMA-IR homeostasis model assessment-insulin resistance index, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, CRP C-reactive protein, ALT alanine aminotransferase, AST aspartate aminotransferase, GGT gamma-glutamyl transpeptidase, NAFLD non-alcoholic fatty liver disease